ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $16,110,000 | +30.8% | 907,057 | +1.7% | 0.00% | +100.0% |
Q2 2018 | $12,313,000 | +236.1% | 892,230 | +121.3% | 0.00% | – |
Q1 2018 | $3,664,000 | -59.3% | 403,131 | -80.8% | 0.00% | -100.0% |
Q4 2017 | $8,995,000 | +161.0% | 2,101,715 | -14.0% | 0.00% | – |
Q3 2017 | $3,446,000 | -35.1% | 2,444,092 | -31.0% | 0.00% | -100.0% |
Q2 2017 | $5,310,000 | -41.1% | 3,540,203 | +0.9% | 0.00% | 0.0% |
Q1 2017 | $9,018,000 | +1.5% | 3,509,035 | +0.7% | 0.00% | 0.0% |
Q4 2016 | $8,885,000 | -16.9% | 3,484,410 | +0.7% | 0.00% | 0.0% |
Q3 2016 | $10,694,000 | -4.2% | 3,460,740 | -0.5% | 0.00% | -50.0% |
Q2 2016 | $11,167,000 | +0.3% | 3,478,712 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $11,132,000 | -22.4% | 3,590,999 | +0.4% | 0.00% | 0.0% |
Q4 2015 | $14,338,000 | -12.5% | 3,575,595 | -0.1% | 0.00% | 0.0% |
Q3 2015 | $16,391,000 | -17.3% | 3,578,915 | -6.3% | 0.00% | -33.3% |
Q2 2015 | $19,825,000 | -35.7% | 3,819,873 | -22.4% | 0.00% | -25.0% |
Q1 2015 | $30,810,000 | -2.1% | 4,921,723 | -1.6% | 0.00% | 0.0% |
Q4 2014 | $31,475,000 | +1.3% | 5,003,915 | -2.1% | 0.00% | 0.0% |
Q3 2014 | $31,062,000 | -12.8% | 5,108,923 | -5.5% | 0.00% | -20.0% |
Q2 2014 | $35,616,000 | -75.5% | 5,404,572 | -11.4% | 0.01% | -75.0% |
Q1 2014 | $145,200,000 | +283.7% | 6,098,292 | +72.3% | 0.02% | +300.0% |
Q4 2013 | $37,846,000 | -11.7% | 3,540,315 | +10.1% | 0.01% | -28.6% |
Q3 2013 | $42,880,000 | +67.8% | 3,216,815 | +65.3% | 0.01% | +75.0% |
Q2 2013 | $25,552,000 | – | 1,946,041 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|